CORVIDIA
Corvidia Therapeutics is a clinical stage company focused on the research, development, and commercialization of transformative therapies for cardio-renal diseases. The Company is currently developing potential treatments for chronic kidney disease with atherosclerotic cardiovascular disease and inflammation, and high triglyceride-induced acute pancreatitis.
CORVIDIA
Social Links:
Industry:
Biotechnology Genetics Health Care Medical Therapeutics
Founded:
2014-01-01
Address:
Waltham, Massachusetts, United States
Country:
United States
Website Url:
http://www.corvidiatx.com
Total Employee:
11+
Status:
Active
Contact:
781-205-4755
Email Addresses:
[email protected]
Total Funding:
86.83 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail WordPress 5.8 Mimecast Dyn DNS SingleHop
Current Advisors List
Founder
Investors List
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Convertible Note - Corvidia
Sofinnova Partners
Sofinnova Partners investment in Series B - Corvidia
MedImmune
MedImmune investment in Series B - Corvidia
Andera Partners
Andera Partners investment in Series B - Corvidia
Cormorant Asset Management
Cormorant Asset Management investment in Series B - Corvidia
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Series B - Corvidia
Venrock
Venrock investment in Series B - Corvidia
Fresenius Medical Care
Fresenius Medical Care investment in Series B - Corvidia
Apple Tree Partners
Apple Tree Partners investment in Series B - Corvidia
Venrock Healthcare Capital Partners
Venrock Healthcare Capital Partners investment in Series B - Corvidia
Official Site Inspections
http://www.corvidiatx.com
- Host name: a67c48129651a0940.awsglobalaccelerator.com
- IP address: 76.223.67.189
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
